SCHEMBL2005291

SCHEMBL2005291

COc1c(C(=O)Cl)cccc1S(=O)(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CA5A P35218 1/20 0.39
F2 P00734 1/20 0.37
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
TRPV4 Q9HBA0 1/20 0.37
MMP2 P08253 3/20 0.35
MMP9 P14780 3/20 0.35
MMP8 P22894 3/20 0.35
MMP12 P39900 3/20 0.35
MMP13 P45452 3/20 0.35
MMP14 P50281 3/20 0.35
MMP16 P51512 3/20 0.35
ALOX15 P16050 2/20 0.35
ALDH1A1 P00352 2/20 0.35
FABP4 P15090 1/20 0.34
MMP3 P08254 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004907 0.87 F2 (0.47) CA1CA2CA9CA5AF2
SCHEMBL11138757 0.82 TRPV4 (0.46) CA1CA2CA9CA5AF2
SCHEMBL699716 0.82 ALDH1A1 (0.45) CA1CA2CA9ALOX15ALDH1A1
SCHEMBL12569842 0.77 ALDH1A1 (0.38) CA1CA2CA9CA5AMMP2
SCHEMBL7666396 0.77 ALDH1A1 (0.49) ALOX15ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3645882 0.76 ALDH1A1 (0.48) CA1CA2CA9CA5AF2
SCHEMBL2009654 0.76 ALDH1A1 (0.51) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL628149 0.75 ALDH1A1 (0.42) CA1CA2CA9CA5AF2
SCHEMBL5011915 0.75 ALDH1A1 (0.47) ALOX15ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL341330 0.75 NPC1 (0.53) CA1CA2CA9ALDH1A1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1864976-B1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-10-10 EP disclosed
US-7960562-B2 Propane-1,3-dione derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-06-14 US disclosed
US-7960562-B2 Propane-1,3-dione derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-06-14 US disclosed
CN-101142193-B 1, 3-propanedione derivative or salt thereof ASTELLAS PHARMA INC 2010-12-29 CN disclosed
US-20090181964-A1 Propane-1,3-Dione Derivative or Salt Thereof ASTELLAS PHARMA INC. 2009-07-16 US disclosed
US-20090181964-A1 Propane-1,3-Dione Derivative or Salt Thereof ASTELLAS PHARMA INC. 2009-07-16 US disclosed
CN-101142193-A 1, 3-propanedione derivative or salt thereof ASTELLAS PHARMA INC (JP) 2008-03-12 CN disclosed
EP-1864976-A1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-12-12 EP disclosed
EP-1864976-A1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181964-A1 Propane-1,3-Dione Derivative or Salt Thereof GNRHR, KISS1R, FSHR CA1 1627/4885CA2 289/4885CA9 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.